Fresenius Medical Care successfully executes strategic plan and narrows guidance range due to strong operational performance in the first half of 2023
– Organic growth accelerated in the second quarter in Care Enablement and Care Delivery including sequentially stable treatment volumes in the U.S. – Execution on turnaround plan translates into visible productivity improvements in Care Delivery achieving a Q2 margin at Mehr



